Our findings suggest that GDF15 may serve as both a diagnostic biomarker to distinguish PVOD from other PAH subtypes and a prognostic biomarker for patients with PVOD, IPAH, and HPAH. This evidence concerns the gene GDF15 and pulmonary arterial hypertension.